
Work Here?
AcuityMD offers a SaaS platform for the MedTech industry to identify target markets, surface top opportunities, and grow revenue across the product lifecycle. It turns large healthcare data into intuitive workflows that align sales and marketing with the overall commercial process. The platform includes market research, growth opportunity spotting, and sales strategy optimization available by subscription. Its goal is to improve market focus and accelerate revenue growth, helping medical devices reach patients faster.
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$163M
Headquarters
Boston, Massachusetts
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$163M
Above
Industry Average
Funded Over
4 Rounds
Industry standards
Remote Work Options
Flexible Work Hours
Unlimited Paid Time Off
Paid Health, Dental, and Vision Plans
Home Office Stipend
Learning Budget
Parental Leave
Company Equity
Optional Team Retreats
AcuityMD, an AI platform for the medical technology industry, has been named to the 2026 Inc. 5000 list at No. 316. The Boston-based company achieved 1,061% three-year revenue growth, roughly 10 times the median rate among honorees. Sixteen of the top 20 medical device companies use AcuityMD to identify target markets and prioritise physicians. The platform has helped over 500 customers identify more than $34 billion in pipeline. In April, AcuityMD announced $80 million in new funding and launched AcuityAI, purpose-built AI tools for MedTech commercial teams. The company has raised upwards of $160 million and is valued at $955 million. This marks AcuityMD's first appearance on the prestigious annual ranking.
AcuityMD now trusted by more than 500 medical device companies, including 16 of top 20. July 22, 2026 Rapid growth reflects seismic shift toward greater use of AI across the MedTech industry BOSTON - July 22, 2026 - AcuityMD, the AI platform for MedTech, today announced it is now trusted by more than 500 medical device (MedTech) companies, including 16 of the top 20, such as Becton Dickinson, Olympus, and Teleflex. The milestone reflects a growing shift across the medical device industry, as commercial teams adopt AI to better understand where care is happening and to uncover new opportunities. Across its customer base, AcuityMD has helped commercial teams generate billions in pipeline opportunities in the past year alone. Now, with AcuityAI, the company expects even faster growth and adoption of AI. MedTech companies face mounting pressure to launch innovations in an increasingly complex healthcare market. Physician movement, shifting sites of care, the growth of Ambulatory Surgical Centers (ASCs), hospital consolidation, and evolving reimbursement policies are constantly reshaping commercial opportunities. No company can track these changes alone. AcuityMD solves this challenge by bringing together the commercial context that's fragmented across dozens of internal and external data sources. Through its proprietary MedTech ontology - which maps physicians, facilities, health systems, products, contracts, and reimbursement dynamics - AcuityMD gives commercial teams a unified and continuously updated view of the healthcare market. With AcuityAI, teams can ask questions in natural language and receive AI-powered recommendations grounded in real-world market data, identify target markets, prioritize high-value physicians, and uncover opportunities that would otherwise take hours to find. Those insights quickly translate into action. AcuityAI has already helped customers generate thousands of accurate call plans, saving sales reps roughly 180 hours of preparation time each year - the equivalent of about a month's worth of work. "What makes this milestone meaningful is not the number itself, but rather the impact our customers are creating with the platform," said Lee Smith, AcuityMD Co-founder and Vice President of Customer Experience. "As AI becomes a bigger part of how MedTech companies operate, we are committed to enabling our customers to make smarter commercial decisions. We will continue investing in AI so our growing customer community can identify the best opportunities faster, and drive stronger results." In related news, AcuityMD just released a new report, AI Adoption in MedTech Sales: 2026 Industry Benchmarks and Trends, revealing MedTech sales reps who use AI are three times more likely to meet or exceed quota than those who do not. The report also shows that among AI users, 92% reported saving at least four hours each week. Yet, most reps only use AI for tactical tasks - less than two out of ten reps currently use AI for account research, despite the strategic value. About AcuityMD. AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies - including 16 of the top 20. Commercial leaders use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. Media contact: Lisa Barbadora, Barbadora INK for AcuityMD +1 (610) 420-3413 [email protected]
AcuityMD has launched its Encounters Data Mart on Snowflake Marketplace, providing medical technology organisations with insights into procedure volumes, provider activity and healthcare delivery locations across the United States. The data mart enables MedTech companies to integrate encounter intelligence directly into their Snowflake environment, supporting commercial and strategy teams with analytics. Customers can allocate up to 25% of their Snowflake Capacity commitment to purchase the product, streamlining procurement. AcuityMD, which serves over 500 MedTech companies including 16 of the top 20, was named to Forbes' 2025 "Next Billion-Dollar Startups" list. The platform combines real-world healthcare data with AI-powered insights to help commercial teams identify target markets and growth opportunities.
AcuityMD launches the AcuityMD Encounters Data Mart on Snowflake Marketplace. Joint customers can access MedTech procedure and provider data directly within Snowflake with the AcuityMD Encounters Data Mart BOSTON-(BUSINESS WIRE)-AcuityMD today announced that it has launched the AcuityMD Encounters Data Mart on Snowflake Marketplace. The AcuityMD Encounters Data Mart provides MedTech organizations with insights into procedure volumes, provider activity, and healthcare delivery locations across the United States, enabling joint customers to quantify market opportunity and identify high-value providers and sites of care. With AcuityMD Encounters Data Mart available on Snowflake Marketplace, customers can seamlessly integrate encounter-level insights into their existing data foundation and accelerate commercial and strategic analytics. Share "MedTech organizations rely on clear visibility into where procedures occur and which providers perform them to make informed commercial decisions," said Alex Wakefield, Chief Revenue Officer at AcuityMD. "By making the AcuityMD Encounters Data Mart available on Snowflake Marketplace, teams can integrate MedTech encounter intelligence into their Snowflake environment and power analytics across commercial and strategy teams." AcuityMD and Snowflake, the AI Data Cloud company, are working together to help joint customers inform business decisions and drive innovation by delivering MedTech encounter, provider, and site-of-care data within the Snowflake AI Data Cloud. With the AcuityMD Encounters Data Mart available in Snowflake, teams across commercial, strategy, and analytics functions can enrich their existing data models with MedTech encounter insights. Customers can also allocate up to 25% of their Snowflake Capacity commitment to purchase the AcuityMD Encounters Data Mart on Snowflake Marketplace, streamlining procurement and maximizing the value of their existing Snowflake investment. "Access to timely, high-quality healthcare data is critical for MedTech organizations looking to identify opportunity and drive growth," said Todd Crosslin, Global Industry Principal Healthcare and Life Sciences, Snowflake. "With AcuityMD Encounters Data Mart available on Snowflake Marketplace, customers can seamlessly integrate encounter-level insights into their existing data foundation and accelerate commercial and strategic analytics. We're excited to support AcuityMD in bringing this capability to the Snowflake ecosystem." Joint customers can now leverage the AcuityMD Encounters Data Mart on Snowflake Marketplace, allowing them to embed procedure and provider intelligence directly into their analytics environment. About AcuityMD AcuityMD is the AI platform for MedTech trusted by over 500 MedTech companies - including 16 of the top 20. Commercial teams use AcuityMD to identify target markets, surface top opportunities, and grow their business. By combining real-world healthcare data with AI-powered insights, AcuityMD enables companies from pre-commercial to enterprise to understand where and how to sell faster to accelerate the adoption of medical technology. AcuityMD was named to Forbes' 2025 "Next Billion-Dollar Startups" list - an elite group of 25 venture-backed U.S. companies identified as most likely to reach a $1 billion valuation. Contacts. Media Contact: Lisa Barbadora, Barbadora INK for AcuityMD +1 (610) 420-3413 [email protected] More News From AcuityMD BOSTON-( BUSINESS WIRE )-AcuityMD, the AI platform for MedTech, today announced $80 million in new funding to elevate its platform with advanced artificial intelligence (AI) capabilities and drive the company's mission of accelerating adoption of medical technology. The Series C round was led by existing investor StepStone Group, with additional participation from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management. Now supporting 16 of the top 20 MedTech companies and having helped c... BOSTON-( BUSINESS WIRE )-AcuityMD, the intelligence platform for MedTech, announced data revealing increased access to colorectal screening and early treatment at ambulatory surgery centers (ASCs). Across the U.S., the majority of all endoscopic colorectal procedures are now performed in ASCs, lowering barriers to care for patients who might delay or avoid screening. ASCs handled nearly 9 million endoscopic colorectal procedures in 2024 alone, a 50% volume increase since 2018. Endoscopic exams... BOSTON-( BUSINESS WIRE )-AcuityMD today announced it has launched AcuityMD for Salesforce on Salesforce AppExchange, the leading enterprise marketplace for partner apps and experts, empowering customers to integrate AcuityMD's platform directly with Salesforce to help commercial teams identify opportunities, research and prioritize targets, and hit sales goals faster. AcuityMD combines accurate and precise data, AI-powered insights, and intuitive workflows to help commercial teams move faster a...
AcuityMD raises $80M Series C, nears $1B valuation. The company will use the funds to enhance its agentic AI capabilities, strengthen its data model and accelerate growth of its MedTech commercial intelligence platform. AcuityMD, which offers a health data tool for the medical technology industry, has secured $80 million in Series C funding, bringing its total raise to more than $160 million and its valuation to $955 million. Existing investor StepStone Group led the round, with participation from Redpoint Ventures, Benchmark, ICONIQ and Atreides Management. WHAT IT DOES Boston-based AcuityMD offers a commercial intelligence platform for MedTech companies, now available in open beta, that combines medical device data from sales to patient outcomes to track the performance of their products, reimbursement dynamics, target physicians and facilities, and map market shares. The company will use the funds to enhance its agentic AI capabilities and data model as well as scale its growth. "AI will transform MedTech, but only with the right context, deeply embedded in the workflows where decisions are made. AcuityMD is that context layer, serving the rep in the field, the commercial leader planning territories and the teams launching the next generation of innovation. I'm grateful to the hundreds of customers who have helped shape our platform," Mike Monovoukas, CEO and cofounder of AcuityMD, said in a statement. "This funding accelerates our shared mission of accelerating adoption of cutting-edge medical technologies." MARKET SNAPSHOT In 2024, AcuityMD scored $45 million in Series B funding, two years after securing $31 million in Series A funding. Another company in the space is Definitive Healthcare, which focuses on the business side of healthcare. The company offers healthcare commercial intelligence, data and analytics with the aim of helping companies analyze care providers, claims and market trends.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
201-500
Company Stage
Series C
Total Funding
$163M
Headquarters
Boston, Massachusetts
Founded
2018
Find jobs on Simplify and start your career today